Vicente Rodríguez Valverde-rekin lankidetzan egindako argitalpenak (6)

2005

  1. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

    Arthritis and Rheumatism, Vol. 52, Núm. 6, pp. 1766-1772

2003

  1. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report

    Arthritis and Rheumatism, Vol. 48, Núm. 8, pp. 2122-2127

1998

  1. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus

    Lupus, Vol. 7, Núm. 3, pp. 159-163

1995

  1. Clinical and serological manifestations of 307 Spanish patients with systemic lupus erythematosus. Comparison with other ethnic groups

    Revista clínica española, Vol. 195, Núm. 8, pp. 534-540

  2. LUPUS ERITEMATOSO SISTEMICO EN VARONES

    Revista Espanola de Reumatologia, Vol. 22, Núm. 7, pp. 268-272

  3. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide

    Rheumatology, Vol. 34, Núm. 8, pp. 737-741